David C Perlman
Dados Biográficos
| ID | 1724853 |
|---|---|
| NOME | David C Perlman |
| PRENOMES | David C |
| SOBRENOME | Perlman |
| ASSINATURA | PERLMAN D C |
| AFILIAÇÕES | Mount Sinai Beth Israel |
| ORCID | 0000-0001-5674-025X |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 38 |
| TOTAL DE CITAÇÕES | 21 |
| TOTAL COMO AUTOR | 38 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 1981 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 3 |
Epidemics and Social Metabolism
David E. Perlman and Ashly Vigneault explore the linkages between humanity's metabolic rift with nature and the accelerating emergence of epidemics, which are fundamentally related to the capitalist mode of production and concomitant alienated social metabolism. Using historical and epidemiological research that extends from the rise of the bubonic plague to the emergence of COVID-19, Perlman and Vigneault are able to deftly tie these concepts to…
“New Normal
Syringe services programs (SSPs) provide critical evidence-based public health services that decrease harms from drug use for people who use drugs (PWUD). Many SSPs have experienced significant and evolving COVID-19-related disruptions. We aimed to characterize the impacts of COVID-19 on SSP operations in the United States approximately two years into the pandemic. teleconference and brief electronic survey evaluating the impacts of COVID-19 on p…
Dialectical Processes of Health Framework as an Alternative to Social Determinants of Health Framework
The social determinants of health (SDOH) framework has proven useful for research and practice in addressing the social causes of many health outcomes. However, its limitations may restrict its value as the world undergoes rapid ecological and social change. We argue that SDOH does not adequately incorporate rapidly changing or “far upstream” social processes (particularly social movements), the dialectics of social conflict and creative social i…
Historical and theoretical roots of the big events framework
Lessons from the First Wave of Covid-19 for Improved Medications for Opioid Use Disorder (Moud) Treatment
Background Medications for Opioid Use Disorder (MOUD) are associated with important public health benefits. Program changes implemented in response to COVID-19 hold promise as ongoing strategies to improve MOUD treatment. Methods: MOUD patients on buprenorphine or methadone, providers, government regulators, and persons who use drugs not in MOUD were recruited in the Northeast region of the United States between June and October of 2020 via adver…
Emerging Zoonotic Infections, Social Processes and Their Measurement and Enhanced Surveillance to Improve Zoonotic Epidemic Responses
Zoonotic epidemics and pandemics have become frequent. From HIV/AIDS through COVID-19, they demonstrate that pandemics are social processes as well as health occurrences. The roots of these pandemics lie in changes in the socioeconomic interface between humanity and non-human host species that facilitate interspecies transmission. The degree to which zoonoses spread has been increased by the greater speed and extent of modern transportation and t…
Barriers to engaging people who use drugs in harm reduction services during the Covid-19 pandemic
Acceptability and Effectiveness of Hepatitis C Care at Syringe Service Programs for People Who Inject Drugs in New York City
Introduction/Objectives: The incidence of hepatitis C (HCV) infection is rising among people who inject drugs (PWID). Even in the context of known HCV prevention and treatment strategies, some PWID remain unengaged in HCV care. This study aimed to identify and characterize experiences and perceptions of PWID regarding the acceptability and effectiveness of HCV testing and treatment at a local syringe service program (SSP). Methods: A total of 36 …
Big Events theory and measures may help explain emerging long-term effects of current crises
Big Events are periods during which abnormal large-scale events like war, economic collapse, revolts, or pandemics disrupt daily life and expectations about the future. They can lead to rapid change in health-related norms, beliefs, social networks and behavioural practices. The world is undergoing such Big Events through the interaction of COVID-19, a large economic downturn, massive social unrest in many countries, and ever-worsening effects of…
Chronic High Risk Prescription Opioid Use Among Persons With HIV
Persons with HIV (PWH) are a population at risk for adverse sequelae of opioid use. Yet, few studies have examined correlates of chronic high risk opioid use and its impact on HIV outcomes. Trends in prescribing patterns and identification of factors that impact the use of opioid prescriptions among PWH are crucial to determine prevention and treatment interventions. This study examined electronic medical records (EMR) of patients receiving HIV c…
The Opioid/Overdose Crisis as a Dialectics of Pain, Despair, and One-Sided Struggle
The opioid/overdose crisis in the United States and Canada has claimed hundreds of thousands of lives and has become a major field for research and interventions. It has embroiled pharmaceutical companies in lawsuits and possible bankruptcy filings. Effective interventions and policies toward this and future drug-related outbreaks may be improved by understanding the sociostructural roots of this outbreak. Much of the literature on roots of the o…
Disinformation, Misinformation and Inequality-Driven Mistrust in the Time of Covid-19
Bundling Rapid Human Immunodeficiency Virus and Hepatitis C Virus Testing to Increase Receipt of Test Results
BACKGROUND: The overlapping human immunodeficiency virus (HIV) and hepatitis C virus (HCV) epidemics disproportionately affect people with substance use disorders. However, many people who use substances remain unaware of their infection(s). OBJECTIVE: The objective of this study was to examine the efficacy of an on-site bundled rapid HIV and HCV testing strategy in increasing receipt of both HIV and HCV test results. RESEARCH DESIGN: Two-armed r…
Using the multiphase optimization strategy (Most) to optimize an HIV care continuum intervention for vulnerable populations
ClinicalTrials.gov, NCT02801747 , Registered June 8, 2016
Racial/Ethnic Disparities at the End of an HIV Epidemic
Objectives. To examine whether racial/ethnic disparities persist at the “end of the HIV epidemic” (prevalence of untreated HIV infection Methods. We recruited 2404 PWID entering New York City substance use treatment in 2001 to 2005 and 2011 to 2015. We conducted a structured interview, and testing for HIV and herpes simplex virus 2 (HSV-2; a biomarker for high sexual risk). We estimated incidence by using newly diagnosed cases of HIV. Disparity a…
Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization
People who use drugs (PWUDs) are at increased risk for several medical conditions, yet they delay seeking medical care and utilize emergency departments (EDs) as their primary source of care. Limited research regarding perceived discrimination and PWUDs' use of health care services exists. This study explores the association between interpersonal and institutional racial/ethnic and drug use discrimination in health care settings and health care u…
Consistent Estimates of Very Low HIV Incidence Among People Who Inject Drugs
Objectives. To compare methods for estimating low HIV incidence among persons who inject drugs. Methods. We examined 4 methods in New York City, 2005 to 2014: (1) HIV seroconversions among repeat participants, (2) increase of HIV prevalence by additional years of injection among new injectors, (3) the New York State and Centers for Disease Control and Prevention stratified extrapolation algorithm, and (4) newly diagnosed HIV cases reported to the…
Strategies to uncover undiagnosed HIV infection among heterosexuals at high risk and link them to HIV care with high retention
ClinicalTrials.gov, NCT01607541, Registered May 23, 2012
Hybrid STTR intervention for heterosexuals using anonymous HIV testing and confidential linkage to care
ClinicalTrials.gov, NCT02421159 , Registered April 15, 2015
Behavioral Intervention Improves Treatment Outcomes Among HIV-Infected Individuals Who Have Delayed, Declined, or Discontinued Antiretroviral Therapy
Providing ART to HIV Seropositive Persons Who Use Drugs
Perceptions of genetic testing and genomic medicine among drug users
An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs
Using qualitative data, people's perceptions, and the science of decision making to inform policy and improve hepatitis C care for people who use drugs
Theory, Measurement and Hard Times
Providing Hepatitis B Vaccination to Injection Drug Users
Injection drug users (IDUs) are at very high risk for infection with hepatitis B virus (HBV) through multiperson use of injection equipment and through unprotected sexual contact. Although a safe and efficacious vaccine exists for hepatitis B, there are multiple problems in vaccinating IDUs in the United States, including (1) discrimination against drug users by health care providers, (2) the need to reach IDUs before they are exposed to HBV, (3)…
Doing a shotgun
Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization
People who use drugs (PWUDs) are at increased risk for several medical conditions, yet they delay seeking medical care and utilize emergency departments (EDs) as their primary source of care. Limited research regarding perceived discrimination and PWUDs' use of health care services exists. This study explores the association between interpersonal and institutional racial/ethnic and drug use discrimination in health care settings and health care u…
Consistent Estimates of Very Low HIV Incidence Among People Who Inject Drugs
Objectives. To compare methods for estimating low HIV incidence among persons who inject drugs. Methods. We examined 4 methods in New York City, 2005 to 2014: (1) HIV seroconversions among repeat participants, (2) increase of HIV prevalence by additional years of injection among new injectors, (3) the New York State and Centers for Disease Control and Prevention stratified extrapolation algorithm, and (4) newly diagnosed HIV cases reported to the…
Associations Between Herpes Simplex Virus Type 2 and HCV With HIV Among Injecting Drug Users in New York City
Objectives. We examined relationships between herpes simplex virus type 2 (HSV-2), a biomarker for sexual risk, and HCV, a biomarker for injecting risk, with HIV among injecting drug users (IDUs) who began injecting after large-scale expansion of syringe exchange programs in New York City. Methods. We recruited 337 heroin and cocaine users who began injecting in 1995 or later from persons entering drug detoxification. We administered a structured…
Persistence and Change in Disparities in HIV Infection Among Injection Drug Users in New York City After Large-Scale Syringe Exchange Programs
Objectives. We examined racial/ethnic disparities in HIV infection among injection drug users (IDUs) before and after implementation of large-scale syringe exchange programs in New York City. Methods. Participants were recruited from IDUs entering the Beth Israel drug detoxification program in New York City. Participants (n = 1203) recruited from 1990 through 1994, prior to large-scale syringe exchange programs (pre-exchange), were compared with …
A Randomized Trial of a Hepatitis Care Coordination Model in Methadone Maintenance Treatment
Objectives. We evaluated the efficacy of a hepatitis care coordination intervention to improve linkage to hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccination and clinical evaluation of hepatitis C virus (HCV) infection among methadone maintenance patients. Methods. We conducted a randomized controlled trial of 489 participants from methadone maintenance treatment programs in San Francisco, California, and New York City from February 2…
Reporting science …informed citizeny
Journal Article Reporting science ...informed citizeny Get access David Perlman David Perlman 1Science Editor San Francisco Chronicle Search for other works by this author on: Oxford Academic Google Scholar Journal of Communication, Volume 31, Issue 4, December 1981, Pages 221–222, https://doi.org/10.1111/j.1460-2466.1981.tb00470.x Published: 07 February 2006
Responses & Reconsiderations
Doing a shotgun
Cost-Effectiveness of Tuberculosis Screening and Observed Preventive Therapy for Active Drug Injectors at a Syringe-Exchange Program
Providing Hepatitis B Vaccination to Injection Drug Users
Injection drug users (IDUs) are at very high risk for infection with hepatitis B virus (HBV) through multiperson use of injection equipment and through unprotected sexual contact. Although a safe and efficacious vaccine exists for hepatitis B, there are multiple problems in vaccinating IDUs in the United States, including (1) discrimination against drug users by health care providers, (2) the need to reach IDUs before they are exposed to HBV, (3)…
Impact of Monetary Incentives on Adherence to Referral for Screening Chest X-rays After Syringe Exchange-Based Tuberculin Skin Testing
Why some injection drug users lick their needles
Persistence and Change in Disparities in HIV Infection Among Injection Drug Users in New York City After Large-Scale Syringe Exchange Programs
Objectives. We examined racial/ethnic disparities in HIV infection among injection drug users (IDUs) before and after implementation of large-scale syringe exchange programs in New York City. Methods. Participants were recruited from IDUs entering the Beth Israel drug detoxification program in New York City. Participants (n = 1203) recruited from 1990 through 1994, prior to large-scale syringe exchange programs (pre-exchange), were compared with …
Syphilis in drug users in low and middle income countries
Associations Between Herpes Simplex Virus Type 2 and HCV With HIV Among Injecting Drug Users in New York City
Objectives. We examined relationships between herpes simplex virus type 2 (HSV-2), a biomarker for sexual risk, and HCV, a biomarker for injecting risk, with HIV among injecting drug users (IDUs) who began injecting after large-scale expansion of syringe exchange programs in New York City. Methods. We recruited 337 heroin and cocaine users who began injecting in 1995 or later from persons entering drug detoxification. We administered a structured…
Theory, Measurement and Hard Times
Combined HIV Prevention, the New York City Condom Distribution Program, and the Evolution of Safer Sex Behavior Among Persons Who Inject Drugs in New York City
Use of the “NYC Condom” among People Who Use Drugs
A Randomized Trial of a Hepatitis Care Coordination Model in Methadone Maintenance Treatment
Objectives. We evaluated the efficacy of a hepatitis care coordination intervention to improve linkage to hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccination and clinical evaluation of hepatitis C virus (HCV) infection among methadone maintenance patients. Methods. We conducted a randomized controlled trial of 489 participants from methadone maintenance treatment programs in San Francisco, California, and New York City from February 2…
Strategies to uncover undiagnosed HIV infection among heterosexuals at high risk and link them to HIV care with high retention
ClinicalTrials.gov, NCT01607541, Registered May 23, 2012
Hybrid STTR intervention for heterosexuals using anonymous HIV testing and confidential linkage to care
ClinicalTrials.gov, NCT02421159 , Registered April 15, 2015
Behavioral Intervention Improves Treatment Outcomes Among HIV-Infected Individuals Who Have Delayed, Declined, or Discontinued Antiretroviral Therapy
Providing ART to HIV Seropositive Persons Who Use Drugs
Perceptions of genetic testing and genomic medicine among drug users
An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs
Using qualitative data, people's perceptions, and the science of decision making to inform policy and improve hepatitis C care for people who use drugs
Consistent Estimates of Very Low HIV Incidence Among People Who Inject Drugs
Objectives. To compare methods for estimating low HIV incidence among persons who inject drugs. Methods. We examined 4 methods in New York City, 2005 to 2014: (1) HIV seroconversions among repeat participants, (2) increase of HIV prevalence by additional years of injection among new injectors, (3) the New York State and Centers for Disease Control and Prevention stratified extrapolation algorithm, and (4) newly diagnosed HIV cases reported to the…
Using the multiphase optimization strategy (Most) to optimize an HIV care continuum intervention for vulnerable populations
ClinicalTrials.gov, NCT02801747 , Registered June 8, 2016
Racial/Ethnic Disparities at the End of an HIV Epidemic
Objectives. To examine whether racial/ethnic disparities persist at the “end of the HIV epidemic” (prevalence of untreated HIV infection Methods. We recruited 2404 PWID entering New York City substance use treatment in 2001 to 2005 and 2011 to 2015. We conducted a structured interview, and testing for HIV and herpes simplex virus 2 (HSV-2; a biomarker for high sexual risk). We estimated incidence by using newly diagnosed cases of HIV. Disparity a…
Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization
People who use drugs (PWUDs) are at increased risk for several medical conditions, yet they delay seeking medical care and utilize emergency departments (EDs) as their primary source of care. Limited research regarding perceived discrimination and PWUDs' use of health care services exists. This study explores the association between interpersonal and institutional racial/ethnic and drug use discrimination in health care settings and health care u…
Medicine (33 obras) · HIV, Drug Use, Sexual Risk (23 obras) · HIV/AIDS Research and Interventions (19 obras) · Psychiatry (19 obras) · Family medicine (15 obras) · Environmental health (14 obras) · Public health (14 obras) · Virology (12 obras) · Nursing (11 obras) · Internal Medicine (10 obras)